Physician profile
Junyang Lou
NPI 1336315712
$9,889.01
in general payments reported to CMS, 2019-2025
23 companies · $907 in 2025
The $907 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,477 · 2020: $1,382 · 2021: $640 · 2022: $799 · 2023: $2,287 · 2024: $397 · 2025: $907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,838 · Travel and Lodging: $1,753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,838.38 |
| Travel and Lodging | $1,752.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $3,062.50 | 2019 | |
| Medtronic, INC. | $1,932.51 | 2023-2025 | Micra, Venaseal |
| Cardiovascular Systems INC. | $1,541.49 | 2019-2022 | |
| Amgen INC. | $1,204.75 | 2021-2025 | Repatha, Repatha |
| Abbott Laboratories | $568.60 | 2019-2025 | Ultreon, Coroflow, Diamondback Peripheral |
| Shockwave Medical, INC | $450.51 | 2019-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $279.04 | 2019-2021 | |
| Abiomed | $264.32 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $100.00 | 2025 | Onpattro |
| Cordis US Corp. | $74.11 | 2022 | |
| Terumo Medical Corporation | $69.72 | 2022 | |
| Philips North America LLC | $48.19 | 2019 | |
| Novartis Pharmaceuticals Corporation | $42.41 | 2025 | |
| Boston Scientific Corporation | $41.04 | 2019-2021 | |
| Angiodynamics, INC. | $39.84 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $28.95 | 2025 | Arista |
| Cathworks, INC. | $24.97 | 2024 | Ffrangio |
| Recor Medical INC | $24.88 | 2024 | Paradise Renal Denervation System |
| Hydrofera LLC | $23.26 | 2024 | Cutimed Sorbact |
| Smith+Nephew, INC. | $20.56 | 2025 | Grafix Pl |
| Medtronic Vascular, INC. | $19.10 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.30 | 2019 | |
| Cardinal Health 200 LLC | $13.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Junyang Lou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.